NCT00239876View on ClinicalTrials.gov

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2005

Conditions
Renal Transplantation
Interventions
DRUG

FTY720

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY